By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Stealth Peptides Inc. 



Rockville  Maryland    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS








Company News
Stealth Peptides Inc. Release: Leading Cardiovascular Researchers Present Promising Bendavia Findings at 2013 European Society of Cardiology Heart Failure Congress 6/24/2013 9:38:39 AM
Stealth Peptides Inc. Reports Successful Clinical Study of Oral Bendavia 1/22/2013 9:29:44 AM
Stealth Peptides Inc. Initiates Patient Enrollment for Novel Treatment of Acute Kidney Injury 1/16/2013 9:30:59 AM
Stealth Peptides Inc. Reports Results from Phase I Clinical Drug Interaction Studies with Bendavia 4/9/2012 9:32:51 AM
Stealth Peptides Inc. Release: Dr. Robert Kloner Presents Bendavia Research at 2011 American Heart Association Annual Meeting 11/28/2011 10:51:14 AM
Stealth Peptides Inc. Release: Researchers Present Promising Bendavia Findings at Annual Stealth Peptides Inc. Meeting 11/15/2011 7:16:21 AM
Stealth Peptides Inc. Release: Bendavia Presented at 2011 American Heart Association’s Cardiovascular Scientific Sessions 8/1/2011 8:26:03 AM
Stealth Peptides Inc. Announces Results from Renal Impairment Clinical Study 6/27/2011 10:03:30 AM
Stealth Peptides Inc.' Bendavia(TM) Recognized as One of Stealth Peptides Inc.'s Top 10 Cardiovascular and Metabolic Development Programs to Watch 11/8/2010 9:53:39 AM
Stealth Peptides Inc. Announces Clinical Phase I Results With Bendavia(TM) Demonstrating Safety And Tolerability With Highly Predictable Pharmacokinetics 9/13/2010 9:28:17 AM
12
//-->